Switch to:
More From Other Websites
ALEXION PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report Apr 29 2016
Alexion Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ALXN-US :... Apr 29 2016
ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Apr 28 2016
How Did XBI’s Large Caps Perform? Apr 28 2016
Edited Transcript of ALXN earnings conference call or presentation 28-Apr-16 2:00pm GMT Apr 28 2016
Alexion (ALXN) Lags Q1 Earnings & Revenues, Revises View Apr 28 2016
Sanofi launches $9.3 billion fight for U.S. cancer firm Medivation Apr 28 2016
Sanofi launches $9.3 bln fight for U.S. cancer firm Medivation Apr 28 2016
Sanofi launches $9.3 bln fight for U.S. cancer firm Medivation Apr 28 2016
Alexion (ALXN) Misses on Q1 Earnings and Revenues Apr 28 2016
[$$] Alexion Profit Declines but Revenue Rises Apr 28 2016
Q1 2016 Alexion Pharmaceuticals Inc Earnings Release - Before Market Open Apr 28 2016
Alexion misses Street 1Q forecasts Apr 28 2016
Alexion misses Street 1Q forecasts Apr 28 2016
6:47 am Alexion Pharma misses by $0.02, misses on revs; guides FY16 revs below consensus Apr 28 2016
Alexion Reports First Quarter 2016 Results Apr 28 2016
Alexion Reports First Quarter 2016 Results Apr 28 2016
Alexion (ALXN) Q1 Earnings: What's in Store for the Stock? Apr 26 2016
4 Biotechs That Will Escape Weak Seasonal Trends for the Sector Apr 26 2016
Why Has Teva Pharmaceutical Targeted Orphan Diseases? Apr 14 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK